Methods, kits and compositions pertaining to the suppression of the detectable probe binding to randomly distributed repeat sequences genomic nucleic acid

1. A mixture of non-nucleotide probes, the probes comprising a nucleobase sequence identical to each of the nucleobase sequences of the group consisting of: Seq. Id. No. 3, Seq. Id. No. 4, Seq. Id. No. 5, Seq. Id. No. 6, Seq. Id. No. 7, Seq. Id. No. 8, Seq. Id. No. 9, Seq. Id. No. 10, Seq. Id. No. 11, Seq. Id. No. 12, Seq. Id. No. 13, and TT(k)TTTTT(k)TTTLysOLysOTTT(k)TTTTT(k)TT, wherein (k) is a D-lysine, Lys is L-lysine, and O is 8-amino-3,6-dioxaoctanoic acid.

2. The probe mixture of claim 1 , wherein the nucleobase sequences are of the group consisting of: Seq. Id. No. 3, Seq. Id. No. 4, Seq. Id. No. 5, Seq. Id. No. 6, Seq. Id. No. 7, Seq. Id. No. 8, Seq. Id. No. 9, Seq. Id. No. 10, Seq. Id. No. 11, Seq. Id. No. 12, Seq. Id. No. 13, Seq. Id. No. 15, Seq. Id. No. 16, Seq. Id. No. 17, Seq. Id. No. 18, Seq. Id. No. 19, Seq. Id. No. 20, Seq. Id. No. 21, Seq. Id. No. 22, Seq. Id. No. 23, Seq. Id. No. 24, Seq. Id. No. 25, TT(k)TTTTT(k)TTTLysOLysOTTT(k)TTTTT(k)TT, and AA(k)AAAAA(k)AAALysOLysOAAA(k)AAAAA(k)AA, wherein (k) is a D-lysine, Lys is L-lysine, and O is 8-amino-3,6-dioxaoctanoic acid.

3. The probe mixture of claim 1 , wherein the non-nucleotide probes are peptide nucleic acid (PNA) probes.

4. The probe mixture of claim 3 , wherein the PNA subunits of the individual PNA probe have the formula:

wherein,

each J is the same or different and is selected from the group consisting of: H, R 1 , OR 1 , SR 1 , NHR 1 , NR 1 2 , F, Cl, Br and I;

each K is the same or different and is selected from the group consisting of: O, S, NH and NR 1 ;

each R 1 is the same or different and is an alkyl group having one to five carbon atoms which may optionally contain a heteroatom or a substituted or unsubstituted aryl group;

each A is selected from the group consisting of a single bond, a group of the formula: —(CJ 2 ) S - and a group of the formula; —(CJ 2 ) S C(O)— wherein, J is defined above and each s is an integer from one to five;

each t is 1 or 2;

each u is 1 or 2; and

each L is the same or different and is independently selected from the group consisting of J, dabcyl, fluorescein, adenine, cytosine, guanine, thymine, uracil, 5-propynyl-uracil, 2-thio-5-propynyl-uracil, 5-methylcytosine, 2-aminopurine, 2-amino-6-chloropurine, 2,6-diaminopurine, hypoxanthine, pseudoisocytosine, 2-thiouracil, 2-thiothymidine, N9-(2-amino-6-chloropurine), N9-(2,6-diaminopurine), N9-(7-deaza-guanine), N9-(7-deaza-8-aza-guanine) and N8-(7-deaza-8-aza-adenine), other naturally occurring nucleobase analogs, other non-naturally occurring nucleobases and substituted and unsubstituted aromatic moieties.

5. The probe mixture of claim 4 , wherein the PNA subunits of the individual PNA probes consist of a naturally or non-naturally occurring nucleobase attached to an aza nitrogen of an N-[2-(aminoethyl)]glycine backbone through a methylene carbonyl linkage.

6. The probe mixture of claim 1 , wherein each probe contains from at least 16 to about 50 nucleobase containing subunits in length.

7. The probe mixture of claim 1 , further comprising one or more detectable nucleic acid probe(s).

8. The probe mixture of claim 7 , wherein the one or more detectable nucleic acid probe(s) have a length of at least 100 base pairs.

9. The probe mixture of claim 1 , further comprising genomic nucleic acid of a sample to be tested.

10. A composition comprising

a) genomic nucleic acid containing one or more segments of randomly distributed repeat sequence selected from the group consisting of SINEs and LINEs; and

b) the mixture of non-nucleotide probes according to claim 1 .

11. A composition comprising

a) a detectable nucleic acid probe of at least 100 bp genomic nucleic acid containing one or more segments of randomly distributed repeat sequence selected from the group consisting of SINEs and LINEs; and

b) the mixture of non-nucleotide probes according to claim 1 .

12. A kit comprising

a) the mixture of non-nucleotide probes according to claim 1 ; and

b) reagents and compositions suitable for performing an assay on a sample and determining a genomic nucleic acid present in the sample.